Pregled bibliografske jedinice broj: 1074767
Indomethacin increases quercetin affinity for human serum albumin: a combined experimental and computational study and its broader implications
Indomethacin increases quercetin affinity for human serum albumin: a combined experimental and computational study and its broader implications // International journal of molecular sciences, 21 (2020), 16; 5740, 14 doi:10.3390/ijms21165740 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1074767 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Indomethacin increases quercetin affinity for human serum albumin: a combined experimental and computational study and its broader
implications
Autori
Rimac, Hrvoje ; Tandarić, Tana ; Vianello, Robert ; Bojić, Mirza
Izvornik
International journal of molecular sciences (1422-0067) 21
(2020), 16;
5740, 14
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
human serum albumin ; quercetin ; indomethacin ; pharmacokinetic interactions ; fluorescence spectroscopy ; docking ; molecular dynamics ; quantum chemistry
Sažetak
Human serum albumin (HSA) is the most abundant carrier protein in human body. Competition for the same binding site between different ligands can lead to an increased active concentration or a faster elimination of one or both ligands. Indomethacin and quercetin both bind to the binding site located in the IIA subdomain. To determine the nature of HSA-indomethacin- quercetin interactions, spectrofluorometric, docking, molecular dynamics studies, and quantum chemical calculations were performed. Results show that indomethacin and quercetin binding sites do not overlap. Moreover, the presence of quercetin does not influence the binding constant and position of indomethacin in the pocket. However, binding of quercetin is much more favorable in the presence of indomethacin, with its position and interactions with HSA significantly changed. These results provide a new insight into drug-drug interactions, which can be important in situations when displacement from HSA or other proteins is undesirable or even desirable. This principle could also be used to deliberately prolong or shorten xenobiotics’ half-life in the body, depending on the desired outcomes.
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Farmacija
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Institut "Ruđer Bošković", Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE